175 related articles for article (PubMed ID: 19664568)
41. Beware of being caught on the rebound.
Lordkipanidzé M; Harrison P
J Thromb Haemost; 2011 Jan; 9(1):21-3. PubMed ID: 21210949
[No Abstract] [Full Text] [Related]
42. Antiplatelet and antithrombotic treatment after primary percutaneous coronary intervention: balancing safety and efficacy.
Valgimigli M; Minarelli M
Am Heart J; 2010 Dec; 160(6 Suppl):S36-41. PubMed ID: 21147290
[TBL] [Abstract][Full Text] [Related]
43. Post-PCI fatal bleeding in aspirin and clopidogrel hyper responder: shifting from antiplatelet resistance to bleeding risk assessment?
Cuisset T; Frere C; Quilici J; Uhry S; Alessi MC; Bonnet JL
Int J Cardiol; 2010 Jan; 138(2):212-3. PubMed ID: 18707772
[TBL] [Abstract][Full Text] [Related]
44. Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial.
Bhatt DL; Flather MD; Hacke W; Berger PB; Black HR; Boden WE; Cacoub P; Cohen EA; Creager MA; Easton JD; Hamm CW; Hankey GJ; Johnston SC; Mak KH; Mas JL; Montalescot G; Pearson TA; Steg PG; Steinhubl SR; Weber MA; Fabry-Ribaudo L; Hu T; Topol EJ; Fox KA;
J Am Coll Cardiol; 2007 May; 49(19):1982-8. PubMed ID: 17498584
[TBL] [Abstract][Full Text] [Related]
45. Randomized comparison of platelet function monitoring to adjust antiplatelet therapy versus standard of care: rationale and design of the assessment with a double randomization of (1) a fixed dose versus a monitoring-guided dose of aspirin and clopidogrel after DES implantation, and (2) treatment interruption versus continuation, 1 year after stenting (ARCTIC) study.
Collet JP; Cayla G; Cuisset T; Elhadad S; Rangé G; Vicaut E; Montalescot G
Am Heart J; 2011 Jan; 161(1):5-12.e5. PubMed ID: 21167334
[TBL] [Abstract][Full Text] [Related]
46. Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention: an analysis from the clopidogrel for the reduction of events during observation trial.
Dosh K; Berger PB; Marso S; van Lente F; Brennan DM; Charnigo R; Topol EJ; Steinhubl S
Circ Cardiovasc Interv; 2009 Dec; 2(6):503-12. PubMed ID: 20031767
[TBL] [Abstract][Full Text] [Related]
47. Residual platelet activity is increased in clopidogrel- and ASA-treated patients with coronary stenting for acute coronary syndromes compared with stable coronary artery disease.
Geisler T; Kapp M; Göhring-Frischholz K; Daub K; Dösch C; Bigalke B; Langer H; Herdeg C; Gawaz M
Heart; 2008 Jun; 94(6):743-7. PubMed ID: 17567647
[TBL] [Abstract][Full Text] [Related]
48. How to optimise clopidogrel therapy? Reducing the low-response incidence by aggregometry-guided therapy modification.
Neubauer H; Lask S; Engelhardt A; Mügge A
Thromb Haemost; 2008 Feb; 99(2):357-62. PubMed ID: 18278186
[TBL] [Abstract][Full Text] [Related]
49. Dual antiplatelet drug resistance in patients with acute coronary syndrome.
Guha S; Sardar P; Guha P; Roy S; Mookerjee S; Chakrabarti P; Deb PK; Chaudhuri U; Deb S; Karmakar R; Dasgupta AK; Lahiri P
Indian Heart J; 2009; 61(1):68-73. PubMed ID: 19729693
[TBL] [Abstract][Full Text] [Related]
50. Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting.
Silberman S; Neukirch-Stoop C; Steg PG
Am J Cardiol; 2005 Feb; 95(4):509-10. PubMed ID: 15695141
[TBL] [Abstract][Full Text] [Related]
51. Diffuse alveolar hemorrhage as a complication of dual antiplatelet therapy for acute coronary syndrome.
Ikeda M; Tanaka H; Sadamatsu K
Cardiovasc Revasc Med; 2011; 12(6):407-11. PubMed ID: 21514251
[TBL] [Abstract][Full Text] [Related]
52. An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial.
Wang TH; Bhatt DL; Fox KA; Steinhubl SR; Brennan DM; Hacke W; Mak KH; Pearson TA; Boden WE; Steg PG; Flather MD; Montalescot G; Topol EJ;
Eur Heart J; 2007 Sep; 28(18):2200-7. PubMed ID: 17673448
[TBL] [Abstract][Full Text] [Related]
53. Real-life management of dual antiplatelet therapy interruption: the REGINA survey.
Collet JP; Aout M; Alantar A; Coriat P; Napoléon B; Thomas D; Trosini-Desert V; Tucas G; Vicaut E; Montalescot G
Arch Cardiovasc Dis; 2009 Oct; 102(10):697-710. PubMed ID: 19913771
[TBL] [Abstract][Full Text] [Related]
54. It is standard practice, but is it really best practice or clinical biocreep?
Gilchrist IC
Catheter Cardiovasc Interv; 2010 Oct; 76(4):525-6. PubMed ID: 20882656
[No Abstract] [Full Text] [Related]
55. Effect size of ticagrelor over clopidogrel in the Platelet Inhibition and Patient Outcomes (PLATO) trial: from statistics to clinical judgment.
Capodanno D; Calvi V; Tamburino C
J Cardiovasc Med (Hagerstown); 2012 Feb; 13(2):162-3. PubMed ID: 22237463
[No Abstract] [Full Text] [Related]
56. [Thienopyridines in the treatment and prevention of cardiovascular diseases. Part V. Combination of clopidogrel and acetylsalicylic acid in the treatment of stable patients with atherothrombotic cardiovascular diseases].
Preobrazhenskiĭ DV; Sidorenko BA; Fettser DV; Batyraliev TA; Niiazova-Karben ZA; Besnili F
Kardiologiia; 2010; 50(5):73-6. PubMed ID: 20831051
[TBL] [Abstract][Full Text] [Related]
57. Prolonged clopidogrel application reduces tissue factor expression after percutaneous coronary intervention in the porcine model.
Ayral Y; Rauch U; Goldin-Lang P; Eisenreich A; Pepke W; Deiner C; Schwimmbeck PL; Schultheiss HP; Pels K
Cardiovasc Revasc Med; 2011; 12(1):47-55. PubMed ID: 21241972
[TBL] [Abstract][Full Text] [Related]
58. Safety and efficacy of triple antithrombotic therapy after percutaneous coronary intervention in patients needing long-term anticoagulation.
Singh PP; Singh M; Bedi U; Molnar J; Arora R; Khosla S
Ther Adv Cardiovasc Dis; 2011 Feb; 5(1):23-31. PubMed ID: 21183532
[TBL] [Abstract][Full Text] [Related]
59. There is no place like home after successful percutaneous coronary intervention.
Gilchrist IC
Catheter Cardiovasc Interv; 2009 Dec; 74(7):1017-8. PubMed ID: 19953518
[No Abstract] [Full Text] [Related]
60. Effectiveness of aspirin and clopidogrel combination therapy in coronary stenting.
Jauhar R; Bergman G; Savino S; Deutsch E; Shaknovich A; Parikh M; Sanborn TA
Am J Cardiol; 1999 Sep; 84(6):726-8, A8. PubMed ID: 10498144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
